# FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1

> **NCT05518071** · PHASE2 · COMPLETED · sponsor: **Leiden University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Pancreas Adenocarcinoma
- Cholangiocarcinoma

## Interventions

- **DRUG:** CRGD-ZW800-1
- **DEVICE:** Intraoperative near-infrared fluorescence imaging

## Key facts

- **NCT ID:** NCT05518071
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-09
- **Primary completion:** 2024-05-23
- **Final completion:** 2024-05-23
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05518071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05518071, "FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05518071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*